Clinical Trial Update: Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Mecapegfilgrastim (PEG-G-CSF) as prophylaxis for chemotherapy-induced neutropenia in lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Lymphoma

Drugs mentioned

• Mecapegfilgrastim

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Chemotherapy-induced Neutropenia, Lymphoma | Phase 2 | Status: UNKNOWN